Publication | Closed Access

WR-1065, the active metabolite of amifostine (ethyol®), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells

Cytotoxic EffectsStandard Anticancer DrugsOncologyMedicineBreast Cancer CellsPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyTumor BiologyOvarian Cancer